The European Union has taken the lead in mandating greater transparency for cosmetic allergens. In July 2023, the EU adopted Regulation (EU) 2023/1545 to update Annex III of the Cosmetics Regulation (EC 1223/2009) and expand the list of fragrance allergens that must be individually labelled from the original 26 to a total of 82 substances.

In practical terms, 56 new fragrance ingredients – including several common essential oils and aroma chemicals like menthol, lemongrass oil, lavandula (lavender) extract and others – have been added to the list of allergens that must be declared on product ingredient lists. These substances join the previously regulated allergens (such as limonene, linalool, etc.), many of which are naturally present in perfumes and botanical extracts.

Under the revised EU rules, any of the listed allergens must be shown on the label if their concentration exceeds 0.001% in leave-on products (e.g. creams, lotions, fragrances) or 0.01% in rinse-off products (e.g. shampoos, soaps). This labeling threshold remains the same as it was for the original 26 allergens. The difference now is simply that many more substances are covered.

The regulation came into force on 16 August 2023, but the EU has provided a generous transition period for industry compliance. Cosmetic manufacturers have until 31 July 2026 to adjust and ensure any new products placed on the EU market comply with the extended allergen disclosure requirements, and products already on the market can continue to be sold until 31 July 2028. After those deadlines, any cosmetic product not labeling the newly added allergens (when present above the threshold) will be non-compliant in the EU market.

It’s worth noting that the EU’s amendment also introduced a practical solution to mitigate label space issues given the long list of ingredients: grouping certain closely related allergens under a single label name. For example, Citral now serves as a group label for the isomers geranial and neral, meaning a product containing either or both would simply list “Citral” on the label.

This grouping approach helps keep ingredient lists manageable and less confusing for consumers, even as the number of declarable allergens increases. Overall, the EU’s extended allergen labelling rule is designed to enhance consumer safety through transparency – empowering the estimated 1–9% of the population allergic to fragrance allergens to make informed choices – without banning these substances outright. Manufacturers are not required to remove the newly listed allergens from their formulas, only to disclose them clearly to consumers.

The European move has set a precedent that other regulatory regimes are beginning to follow. Cosmetics regulators in multiple regions are now implementing stricter disclosure requirements for potential allergens in personal care products. Below is an overview of how key markets are responding to the push for expanded allergen transparency:

• United States: In late 2022, the U.S. enacted the Modernization of Cosmetics Regulation Act (MoCRA), which for the first time mandates fragrance allergen labeling on cosmetics at the federal level. MoCRA’s Section 609(b) requires that “each fragrance allergen included in a cosmetic product” be identified by name on the product label – a significant change from the past policy that allowed hiding ingredients under the generic term “fragrance.” The FDA was tasked with determining which substances qualify as “fragrance allergens” and issuing proposed regulations by mid-2024. However, as of 2025 the rule-making is delayed: a proposed allergen list and labelling rule is now expected around late 2025 . This suggests U.S. companies will soon need to label fragrance allergens in line with whatever list FDA publishes (likely influenced by the EU’s science-based list). In the meantime, individual states have taken initiative. California’s “Cosmetic Fragrance and Flavor Ingredient Right to Know Act” now requires companies selling in CA to report any EU-listed fragrance allergens in their products to the state’s public database (effective January 2024) . This California disclosure is done via a website rather than on the package, but it foreshadows the coming federal requirement and indicates growing demand for transparency.

• Canada: Canada is actively aligning its cosmetics regulations with the EU’s allergen labelling approach. In April 2024, Health Canada published updates to the Cosmetic Regulations to enhance ingredient disclosure. The new Canadian framework established harmonized definitions for “leave-on” and “rinse-off” products (matching the EU terminology) and set a timeline for phasing in the expanded allergen list. For any cosmetic introduced after 1 August 2026, Canada will require all fragrance allergens – both the original set and the 56 new ones – to be listed on the label if they exceed 0.001% in leave-on or 0.01% in rinse-off products . Products already on the Canadian market before that date are initially allowed to continue using the older requirement (disclosing the original 24 allergens above threshold) until the transition is complete. By 1 August 2028, however, all cosmetics on the Canadian market must comply with the full extended allergen disclosure, just like in the EU. Notably, Canada’s regulation even provides flexibility for very small packages – companies can use a website to list ingredients if the label is too small – showing regulators are balancing transparency with practical packaging limitations.

• United Kingdom: The UK, after Brexit, retained the EU Cosmetics Regulation in its own law, including the legacy allergen labelling rules (which covered the original 26 fragrance allergens). As of late 2024, the UK has not yet adopted the EU’s new list of 82 allergens. Cosmetics in Great Britain still only need to label the original allergens above the 0.001%/0.01% thresholds, and no formal decision or timeline for adding the 56 new ones has been announced . In other words, the UK currently requires disclosure of the “initial 24” allergens (two of the EU’s 26 were banned and thus not in use) and has not expanded that list yet. However, industry experts anticipate that the UK will eventually follow a similar approach to keep in step with scientific findings and EU consumer protection standards. Businesses selling in the UK need to monitor developments closely – any future alignment would likely come with its own transition period, but proactive compliance planning is wise.

Overall, the direction is clear: major markets are converging toward more extensive allergen labelling in cosmetics, mirroring the EU’s initiative. This global trend means companies that operate in multiple regions face a moving target – ensuring that labels meet the specific requirements in each jurisdiction (and updating them as regulations evolve). Next, we consider what challenges this poses in practice for cosmetic product companies.

For cosmetic manufacturers and brands, the expanded allergen disclosure rules bring a significant compliance challenge. On the surface, listing an extra few dozen ingredients might sound simple; in reality, it requires deep visibility into product formulations and agile coordination across many departments. Some key challenges include:

• Identifying Hidden Allergens: Many of the newly regulated allergens are not added as stand-alone ingredients, but rather occur as components of complex mixtures, for example, fragrance oils or plant extracts can naturally contain several allergens. Brands must obtain detailed composition data from suppliers (fragrance houses and EO suppliers) to know if any of the 80+ regulated allergens are present in each raw material. It can be daunting to trace these substances across hundreds of formulas in a product portfolio, especially if relying on manual checks.

• Multi-Market Complexity: Regulatory differences mean a product sold in multiple countries might have different labelling requirements over time. For instance, a perfume sold in both the EU and UK might need the new allergens listed on the EU packaging by 2026, but not on the UK packaging (unless the UK catches up). Meanwhile, the same product in the US could soon need allergen labelling per FDA’s forthcoming list. Coordinating these variations without error – while maintaining a consistent brand presentation – is a complex puzzle for global brands. Companies are developing “market-specific labelling strategies” to accommodate local rules while preserving a unified global identity, but executing this manually is time-consuming and error-prone.

• Label space and design constraints: Adding dozens of extra ingredient names to packaging can lead to very crowded labels, especially on small products. The EU addressed this by allowing grouping of similar chemicals under one name, as mentioned earlier, but it’s still a lot of information to fit. Long chemical names can overwhelm the label and potentially confuse consumers. This was explicitly recognized as a challenge during the EU’s amendment process – regulators noted the “issue of space on labels due to the very long list of ingredients”. Companies may need to redesign labels or packaging formats (e.g. fold-out labels) to accommodate the new disclosures legibly.

• Updating product documentation: Beyond the physical label, other compliance documentation must be updated. The Product Information File (PIF) in the EU, safety assessments, and ingredient lists in databases all need revision to reflect the presence of newly declared allergens. This administrative load is not trivial, especially for companies with extensive product portfolios.

• Timeline and change management: The staggered implementation (EU by 2026/2028, Canada by 2026/2028, etc.) gives breathing room, but the clock is ticking. Managing the transition of potentially thousands of product SKUs to new labels by the deadlines requires careful project management. Missteps could result in products being unlawfully on the market after the cutoff dates, or expensive scrap of old inventory. Moreover, if a company decides to reformulate some products to remove certain allergens (perhaps to avoid having to label them, due to consumer perception concerns), that adds R&D burden. In short, companies must thoroughly audit their portfolios for allergen content and plan necessary changes well in advance.

Given these challenges, it’s clear that manual tracking with spreadsheets and static documents will struggle to keep up. This is where modern compliance management software becomes indispensable. In the next section, we look at how the right software tools such as PRIMS can address the above issues and ensure compliance is maintained efficiently.

To manage the influx of new allergen regulations, forward-thinking cosmetics companies are turning to digital solutions – specifically, robust compliance management softwares such as PRIMS – to track ingredients and streamline label updates. PRIMS is designed to trace substances classified as allergens throughout the product portfolio and products’ lifecycle, providing a single source of truth for formulation data, regulatory requirements, and labeling. Here’s how compliance softwares such as PRIMS help solve the practical problems:

• Centralized ingredient database & allergen screening: A good product compliance management platform such as PRIMS allows companies to maintain a comprehensive database of all raw materials and formulas, with detailed composition information broken down into single substances. This means you can log each fragrance oil or natural extract along with any allergens it contains (and at what concentration). The software can then automatically scan all product formulas for the presence of regulated allergens and flag those that exceed the legal thresholds or that require disclosure or warnings on product lables. Rather than manually auditing hundreds of formulas, regulatory teams can generate reports in seconds showing exactly which products contain, say, atranol (oakmoss allergen) or citral above 0.001%. Such automated allergen screening not only saves immense time, it reduces the risk of human error in overlooking an ingredient. This ensures no allergen slips through undisclosed.

• End-to-end traceability across the product lifecycle: PRIMS compliance software ensures that allergen data is connected through every stage of product development – from initial formulation design to final label printing. For example, PRIMS links each ingredient to all the formulas that use it, and those formulas to the finished products. This means any change in an ingredient (say a supplier updates the fragrance composition) is instantly reflected in all associated product records. The moment a new allergen is identified in a raw material, the system can “roll up” that information to every formula and product containing it, automatically propagating the allergen disclosure through the ingredient-formula-product relationships. This level of traceability is virtually impossible to achieve with spreadsheets. PRIMS allows companies to react swiftly when regulations change or new scientific findings emerge – you can query the database, find all products containing a particular substance, evaluate the impact and update them in a coordinated way. The software essentially maps your entire product portfolio’s allergen footprint, providing confidence that nothing is missed.

• Simplifying multi-region Compliance: For brands operating in different regulatory markets, PRIMS compliance specialists maintain configurable rules for each region’s requirements. The supporting regulatory specialists define which allergen list applies to EU vs. US vs. Canada, for example, and the PRIMS system can then validate or generate ingredient labels accordingly. This makes it far easier to develop the “market-specific labelling strategies” needed to meet local rules without maintaining separate manual lists for each country. PRIMS even alerts users if a formula contains an ingredient that is prohibited or triggers special labelling in a given country – helping to avoid regulatory conflicts early in the development process. By centralizing and codifying the varied regulations, PRIMS allows global cosmetics companies to stay agile and compliant everywhere they sell.

• Automated Label and Document updates: PRIMS compliance software includes functionality to generate ingredient lists and compliance documentation automatically from formula data. Once the allergen content is logged in the system, updating a product’s ingredient list for the new labelling rules can be as simple as running a new label report. This is far less error-prone than manually rewriting labels. The software can ensure that the proper INCI names are used (including the grouped names where applicable) and that the allergens appear in the correct order and format. In addition, all supporting documents like safety assessments (CPSR) and Product Information Files can be updated in the electronic repository. In essence, label compliance becomes a more automated, repeatable process rather than a fire-drill for each product.

• Portfolio-wide audits and change planning: With all product data in one system, companies can run portfolio-wide allergen audits and simulations. For instance, you could filter for all products that would require a label change under the EU’s 82-allergen list, and then prioritize those updates by sales volume or risk. This helps in developing a focused compliance action plan. Proactive brands are indeed taking such steps, conducting “allergen audits of their entire product portfolio to identify compliance gaps” and considering reformulations for products where an allergen label might impact consumer perception or when the presence of many allergens is not in line with product USPs. The software greatly facilitates these audits by providing real-time analytics. It can also track the progress of reformulation or relabelling projects and even indicate warnings ahead of regulatory deadlines.

In summary, a reliable compliance management software solution such as PRIMS is the cosmetics manufacturer’s best ally in navigating extended allergen regulations. It creates a living map of every substance in every product, so that when rules evolve, the company can pinpoint exactly what needs to change. By automating allergen tracking and ensuring traceability from the formulation stage through to packaging, a compliance software not only keeps you compliant but also improves efficiency and reduces the likelihood of costly mistakes (like a missed allergen on a label or a needlessly reformulated product). PRIMS essentially eliminates manual allergen tracking complexity by implementing smart logic that automatically propagates allergen claims through ingredient-formula-product relationships, enabling proactive risk management and accurate product safety documentation.

The upcoming expansions to allergen labeling requirements, from the EU’s Annex III changes to parallel moves in the US, Canada, and other markets, mark a new era of transparency in cosmetic products.

Compliance will undoubtedly be challenging, especially for global brands, but it is achievable with diligent planning and the support of modern compliance technology. Companies that invest in robust compliance tech can transform what might seem like a regulatory burden into a well-controlled process. By tracking allergenic substances throughout the product lifecycle and across the entire portfolio, the compliance tools ensure that when the deadline arrives, your product labels are accurate, your documentation is complete, and your customers’ trust in your brand’s safety and honesty remains intact.

In an industry where ingredient transparency is increasingly synonymous with quality, embracing the software-driven compliance solutions is not just about avoiding penalties – it’s about demonstrating a commitment to consumer well-being and staying ahead in a more regulated, safety-conscious cosmetics market.